Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Amyloid ; 19(4): 186-90, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22994303

RESUMO

A middle-aged male suffering from encephalopathy with cerebral amyloid angiopathy (CAA) with amyloid beta (Aß) presented with initial symptoms of transient consciousness disturbance and left visual field photophobia. Lesions with aberrantly high signal on T2-weighted magnetic resonance imaging (MRI) of the brain appeared in the right temporal lobe posterior to the occipital lobe and spread to other areas. Brain biopsy revealed Aß deposits in vascular walls and numerous diffuse plaques in parenchymal areas. Based on MRI findings, Initial corticosteroid therapy with beta methasone effectively improved the neurological symptoms of consciousness disturbance and motor deficits. After corticosteroid therapy was stopped at 4 weeks, recurrence occurred. Additional corticosteroids did not improve clinical symptoms and the patient progressed to a bed-ridden state with a severe consciousness disturbance. Notably, CSF Aß1-42 and CSF Aß1-40 decreased while the recurrent encephalopathy worsened. After intense deterioration, the patient became stable. CSF Aß1-42 increased but remained at a very low level. This case of CAA encephalopathy with apolipoprotein E ϵ4/ϵ4 homozygosity showed Aß deposits in vascular walls and numerous diffuse plaques in parenchymal areas. The clinical course suggests that reduction of CSF Aß1-42 and Aß1-40 might be related to clinical deterioration in cases of encephalopathy.


Assuntos
Peptídeos beta-Amiloides/líquido cefalorraquidiano , Encefalopatias Metabólicas/patologia , Angiopatia Amiloide Cerebral/patologia , Fragmentos de Peptídeos/líquido cefalorraquidiano , Placa Amiloide/patologia , Apolipoproteínas E/genética , Biópsia , Encefalopatias Metabólicas/complicações , Encefalopatias Metabólicas/metabolismo , Angiopatia Amiloide Cerebral/complicações , Angiopatia Amiloide Cerebral/metabolismo , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Lobo Occipital/metabolismo , Lobo Occipital/patologia , Placa Amiloide/líquido cefalorraquidiano , Lobo Temporal/metabolismo , Lobo Temporal/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...